
Home » Targeted Drug Slows Thyroid Cancer
Targeted Drug Slows Thyroid Cancer
August 15, 2012
In a small, placebo-controlled study, vandetanib (Caprelsa), a kinase inhibitor, delayed progression of the most common type of thyroid cancer, French researchers reported.
MedPage Today
MedPage Today
Upcoming Events
-
21Jan
-
26Jan
-
27Jan
-
27Jan
-
09Feb
-
10Feb